PAA would be eligible anyway just by doing the OLE in Australia, irrespective of expanding the study. The single 'Aussie' proviso for funding from Fight MND is that the Primary Investigator for the research to be funded, must be based in Australia.
Pharmaust - Media & News, page-74
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.005(2.56%) |
Mkt cap ! $97.22M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 20.5¢ | 19.5¢ | $91.23K | 455.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 135256 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 86585 | 3 |
View Market Depth
| Last trade - 15.52pm 26/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |